Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 102 | 373 | 248 | 220 | 220 |
| Accounts receivable | 135 | -82 | 200 | -73 | -187 |
| Other Working Capital | -733 | -932 | -546 | 5,748 | 77 |
| Other Operating Activity | -23,359 | -24,421 | -25,083 | -33,115 | -23,661 |
| Operating Cash Flow | $-23,855 | $-25,061 | $-25,180 | $-27,220 | $-23,551 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -24 | -21 | -64 | -75 | -13 |
| Investing Cash Flow | $-24 | $-21 | $-64 | $-75 | $-13 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -55 | -42 | -55 | -54 | -52 |
| Common Stock Issued | 16,038 | 21,356 | 0 | 0 | 84,084 |
| Other Financing Activity | -443 | -2,474 | 0 | 0 | 9,406 |
| Financing Cash Flow | $15,540 | $18,840 | $-55 | $-54 | $93,438 |
| Exchange Rate Effect | -824 | 1,890 | 762 | 2,920 | N/A |
| Beginning Cash Position | 30,580 | 34,932 | 59,470 | 83,899 | 14,025 |
| End Cash Position | 21,417 | 30,580 | 34,932 | 59,470 | 83,899 |
| Net Cash Flow | $-8,339 | $-6,242 | $-25,300 | $-27,349 | $69,874 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,855 | -25,061 | -25,180 | -27,220 | -23,551 |
| Capital Expenditure | -24 | -21 | -64 | -75 | -13 |
| Free Cash Flow | -23,879 | -25,082 | -25,245 | -27,295 | -23,564 |